The next generation of biophysical screening is almost here.

A new Zetasizer era.
Launching September 15.

 

Enabling the Next Generation of Biologics

Biologics development is moving faster than ever, creating new opportunities to improve patient outcomes while introducing new challenges in understanding increasingly sophisticated molecules and processes.

With decades of experience supporting the world's leading pharmaceutical and biotechnology organizations, Malvern Panalytical remains committed to helping scientists generate the confidence and insight needed to advance breakthrough therapies.

Now, we're preparing to unveil something new

 

 
Innovation never stands still, and neither do we at Malvern Panalytical

Register now to unveil the newest innovation in the Zetasizer product family

Introducing a breakthrough approach designed for complete stability characterization at scale.

Join us for an exclusive live event as we unveil a major new addition to the Malvern Panalytical portfolio and reveal a breakthrough analytical platform set to challenge conventional limitations. Be among the first to discover what's next in biologics characterization and hear from our experts about how consistent, reproducible, and scalable data can empower smarter decisions across the development journey.

 

 
 

Powering Confidence in Biologics Development

In biologics development, confidence starts with data. From discovery to QC, reliable insights help you reduce risk, accelerate decision-making, and move promising candidates forward faster.

For more than 50 years, Malvern Panalytical has helped scientists generate the high-quality, reproducible data needed to understand complex biologics, optimize development pathways, and support confident decisions.

 

Why Biologics Scientists Choose Malvern Panalytical?

 

Find the right candidate faster in early development

De-risk stability before it becomes a problem

Resolve heterogeneity in pre-clinical development

Select the most stable biotherapeutic candidate for developability

Build your formulation around stability

 

Our expert insights

 

Want to be first in line for the new era of biologics characterization?

 

Sign up to receive launch updates, product information, and the latest biologics insights directly to your inbox.

 

Discover how complete biologics characterization can help you identify stability, aggregation, binding, and kinetic challenges earlier in development. Subscribe to receive exclusive launch updates, expert insights, and practical guidance to help de-risk your biologics workflow from discovery through to QC.


By submitting this form you will receive be opting in to receive marketing communications from Malvern Panalytical. For more information please read our Privacy Policy. You can unsubscribe at any time by clicking the unsubscribe link found in the footer of our marketing emails.